£6.6m fundraising for BioProgress
UK encapsulation company BioProgress yesterday unveiled plans to raise £6.6 million (€9.4m) through a placement of shares in order to build a new pharmaceutical production plant.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs